The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Nov. 21, 2017

Filed:

Dec. 30, 2014
Applicant:

Bionsil S.r.l. IN Liquidazione, Milan, IT;

Inventors:

Marialuisa Lavitrano, Milan, IT;

Emanuela Grassilli, Monza, IT;

Kristian Helin, Charlottelund, DK;

Assignee:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 48/00 (2006.01); C07H 21/02 (2006.01); C07H 21/04 (2006.01); A61K 31/519 (2006.01); A61K 31/513 (2006.01); A61K 45/06 (2006.01); A61K 31/277 (2006.01); A61K 31/505 (2006.01); A61K 31/506 (2006.01); A61K 31/713 (2006.01);
U.S. Cl.
CPC ...
A61K 31/519 (2013.01); A61K 31/277 (2013.01); A61K 31/505 (2013.01); A61K 31/506 (2013.01); A61K 31/513 (2013.01); A61K 31/713 (2013.01); A61K 45/06 (2013.01);
Abstract

The described invention provides a method of treating a patient with an epithelial cancer comprising administering a composition comprising a therapeutic amount of an inhibitor of a BTK protein and one or more chemotherapeutic agent(s) selected from the group consisting of an antimetabolite, a platinum coordination compound, an alkylating agent and a combination thereof, wherein the composition is effective to reduce one or more of tumor cell growth, tumor cell clonogenicity, tumor cell proliferation, tumor cell viability and tumor volume and the therapeutic amount of the inhibitor of a BTK protein and the one or more chemotherapeutic agent(s) exerts a synergistic effect. The described invention also provides methods of treating a chemotherapy drug-resistant cancer and sensitizing a cancer patient to chemotherapy.


Find Patent Forward Citations

Loading…